NL-OMON46657招募中不适用

Inflammatory Bowel Disease Tracker - IBD Tracker

Center for Microbiome Informatics and Therapeutics, Massachusetts Institute of Technology0 个研究点目标入组 50 人开始时间: 待定最近更新: 2024年8月26日

适应症

试验速览

暂无简介。

•18 years of age or older
•Be able to provide written informed consent prior to screening and to comply with the requirements of the study protocol
•Be able to read and write Dutch sufficiently
•Be able and comfortable to use new technology: the app and the smartwatch for 12 months
•Live / work in proximity of the UMCG to permit sample collection by UMCG clinical team
•Have had diagnosis of ulcerative colitis or Crohn*s Disease confirmed by a clinician for a disease duration of more than 2 years
•Have had quiescent ulcerative colitis or Crohn*s disease for the past 3 months or longer
•Have had most recent episode of active disease within past 24 months
•Have had a stable IBD medication regimen for at least 3 months

•If female, is pregnant or is breast feeding, or intends to become pregnant within the 12- month study period
•Unable to provide informed consent or unwilling to participate
•Use of oral or intravenous antibiotics within 4 weeks prior to screening
•Evidence of untreated infection e.g. Clostridium diffiicile
•Confirmed diagnosis of other serious disease unrelated to ulcerative colitis or Crohn*s disease
•Current alcohol or drug abuse

发起方

Center for Microbiome Informatics and Therapeutics, Massachusetts Institute of Technology